2020
Changes in the dynamics of dengue incidence in South and Central America are possibly due to cross‐population immunity after Zika virus epidemics
Mugabe V, Borja L, Cardoso C, Weaver S, Reis M, Kitron U, Ribeiro G. Changes in the dynamics of dengue incidence in South and Central America are possibly due to cross‐population immunity after Zika virus epidemics. Tropical Medicine And International Health 2020, 26: 272-280. PMID: 33190402, DOI: 10.1111/tmi.13526.Peer-Reviewed Original ResearchConceptsDengue casesLaboratory-confirmed dengue casesDENV vaccine developmentSignificant public health implicationsDengue virus infectionDengue incidenceLong-term surveillance studyCross-species immunityPublic health implicationsIncidence of dengueVirus immunityVirus infectionEpidemiological dataSurveillance studyDengue feverZika virusDisease severityVaccine developmentIncidenceZika epidemicAnnual dengue incidenceZika outbreakHealth implicationsImmunityOverall rate
2019
Accuracy of the SD BIOLINE Dengue Duo for rapid point-of-care diagnosis of dengue
Kikuti M, Cruz J, Rodrigues M, Tavares A, Paploski I, Silva M, Santana P, Tauro L, Silva G, Campos G, Araújo J, Kitron U, Reis M, Ribeiro G. Accuracy of the SD BIOLINE Dengue Duo for rapid point-of-care diagnosis of dengue. PLOS ONE 2019, 14: e0213301. PMID: 30840708, PMCID: PMC6402663, DOI: 10.1371/journal.pone.0213301.Peer-Reviewed Original ResearchConceptsRapid diagnosis testsNon-dengue febrile patientsFebrile patientsHealthy controlsBlood donorsLaboratory-confirmed dengue casesSD BIOLINE Dengue DuoSecondary DENV infectionDengue virus antigenAcute-phase seraDengue diagnostic testsRepresentative serum samplesDengue-endemic regionsDengue-endemic areasSample of casesDENV antibodiesDENV infectionNS1 ELISAPrimary infectionDengue diagnosisMedical treatment decisionsTreatment decisionsVirus antigenRDT accuracyRDT sensitivity